Human Investing’s Albemarle ALB Stock Holding History

Human Investing’s Portfolio ALB Stock Details ALB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,229	Closed	-$272K	–	100
2023 Q1	$272K	Sell	1,229 -270	-18%	-$66.5K	0.07%	88
2022 Q4	$325K	Buy	+1,499	New	+$400K	0.08%	90

Other funds holding ALB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Human Investing's ALB Position: Q2 2023 in Review

Human Investing sold out of Albemarle (ALB) in Q2 2023, closing a stake of 1,229 shares — an estimated $272K sold.

Human Investing first reported a position in ALB in Q4 2022 and held it in 2 quarters. The position peaked at $325K in Q4 2022. 1,023 funds tracked by Wall St. Rank hold ALB as of Q2 2023.

Human Investing reported no remaining Albemarle position as of Q2 2023 after selling out during the quarter.
Human Investing sold 1,229 Albemarle shares in Q2 2023, an estimated $272K.
Human Investing first reported a position in Albemarle in Q4 2022 and held it in 2 quarters.
Human Investing's Albemarle position peaked at $325K in Q4 2022.
1,023 funds tracked by Wall St. Rank held Albemarle as of Q2 2023.

Based on Human Investing's 13F filing for Q2 2023, filed 7 Aug 2023.